GIAMPIETRO, OTTAVIO
 Distribuzione geografica
Continente #
NA - Nord America 19.552
AS - Asia 13.215
EU - Europa 8.606
SA - Sud America 1.291
AF - Africa 281
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 3
Totale 42.975
Nazione #
US - Stati Uniti d'America 18.790
CN - Cina 4.254
SG - Singapore 4.233
IT - Italia 2.525
HK - Hong Kong 1.777
SE - Svezia 1.415
BR - Brasile 1.067
BG - Bulgaria 904
KR - Corea 850
VN - Vietnam 736
UA - Ucraina 677
CA - Canada 655
TR - Turchia 601
FI - Finlandia 591
DE - Germania 561
FR - Francia 540
GB - Regno Unito 472
RU - Federazione Russa 367
CH - Svizzera 295
IN - India 195
JP - Giappone 165
CI - Costa d'Avorio 130
BD - Bangladesh 91
AR - Argentina 75
BE - Belgio 58
MX - Messico 50
ID - Indonesia 39
IQ - Iraq 38
ZA - Sudafrica 36
PK - Pakistan 32
NL - Olanda 31
SA - Arabia Saudita 31
CO - Colombia 29
VE - Venezuela 29
EC - Ecuador 28
AT - Austria 27
ES - Italia 21
IL - Israele 21
PL - Polonia 21
AU - Australia 19
UZ - Uzbekistan 19
CZ - Repubblica Ceca 18
JO - Giordania 17
MA - Marocco 17
PE - Perù 16
CL - Cile 15
IE - Irlanda 15
KE - Kenya 15
SN - Senegal 15
AE - Emirati Arabi Uniti 13
JM - Giamaica 13
KZ - Kazakistan 13
MY - Malesia 12
NP - Nepal 12
BJ - Benin 11
BO - Bolivia 11
EG - Egitto 11
TN - Tunisia 11
UY - Uruguay 11
HU - Ungheria 10
DK - Danimarca 9
HN - Honduras 9
LT - Lituania 9
NG - Nigeria 9
PH - Filippine 9
RO - Romania 9
AL - Albania 8
GR - Grecia 8
PY - Paraguay 8
TT - Trinidad e Tobago 8
NZ - Nuova Zelanda 7
PS - Palestinian Territory 7
BB - Barbados 6
DZ - Algeria 6
LB - Libano 6
OM - Oman 6
AZ - Azerbaigian 5
ET - Etiopia 4
AO - Angola 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EU - Europa 3
GT - Guatemala 3
IR - Iran 3
KW - Kuwait 3
LK - Sri Lanka 3
MO - Macao, regione amministrativa speciale della Cina 3
NO - Norvegia 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BH - Bahrain 2
CG - Congo 2
EE - Estonia 2
GH - Ghana 2
GY - Guiana 2
HT - Haiti 2
LU - Lussemburgo 2
LY - Libia 2
MM - Myanmar 2
MN - Mongolia 2
Totale 42.939
Città #
Singapore 2.473
Ashburn 2.325
Chandler 1.791
Hong Kong 1.762
Hefei 1.221
Fairfield 1.204
San Jose 1.146
Dallas 1.097
Milan 989
Sofia 902
Jacksonville 890
Seoul 844
Woodbridge 818
Santa Clara 779
Beijing 699
Ann Arbor 679
Houston 638
Shanghai 616
Ottawa 576
Seattle 558
New York 540
Wilmington 481
Princeton 397
Izmir 387
Boardman 385
Cambridge 379
Lawrence 348
Nanjing 325
Des Moines 310
Lauterbourg 305
Bern 288
Medford 286
Los Angeles 222
Dearborn 201
Istanbul 173
Tokyo 158
Jüchen 157
Dong Ket 150
Buffalo 145
Ho Chi Minh City 135
Nanchang 134
Marseille 133
Abidjan 130
Helsinki 112
Hanoi 107
Florence 106
Frankfurt am Main 97
Redondo Beach 91
Kunming 90
San Diego 77
São Paulo 77
Rome 68
Boulder 67
The Dalles 67
Pune 66
Tianjin 66
Redwood City 60
Ogden 59
Columbus 56
Brussels 55
Changsha 55
Council Bluffs 55
Shenyang 47
Hebei 42
London 42
Chicago 41
Jiaxing 39
Rio de Janeiro 37
Orem 36
Verona 32
Falls Church 31
Norwalk 31
Guangzhou 30
Orange 30
Chennai 29
Munich 29
Detroit 27
Jinan 27
Serra 27
Brooklyn 25
Da Nang 25
Nuremberg 25
Phoenix 25
Hangzhou 24
Manchester 21
Belo Horizonte 20
Edinburgh 20
Johannesburg 20
Lancaster 20
Porto Alegre 20
Warsaw 20
Auburn Hills 19
Düsseldorf 19
San Francisco 19
Brasília 18
Jakarta 18
Lanzhou 18
Tappahannock 18
Tashkent 18
Toronto 18
Totale 30.614
Nome #
Nonenzymatic glycation of human platelet membrane proteins in vitro and in vivo. 325
H emodynamic and metabolic correlates of microalbuminuria and erytrocyte Na/H exchange in Hypertension. 29th annual meting of the E.S.C.I. Cambridge 2and-5th April 1995. 288
Study of skin vasomotion in type 1 diabetic patients and of its possible relationship with clinical and laboratory variables 238
Improving CardioCheck PA analytical performance: three-year study. 212
Valutazione dell'asse ipotalamo-ipofisi-gonadi nel maschio diabetico. 207
Short-term vs. overnight urine collection for screening of urinary albumin excretion rate. 207
Albuminuria and endothelial dysfunction in hypertensive subjects 207
Epidemiology of cardiovascular disease in patients with type 1 diabetes: European perspective. 207
Su di un caso di galattorrea normoprolattinemica in una donna fertile portatrice di un contraccettivo a base di rame (copper intrauterine device, copper IUD). 205
CardioChek PA cholesterol-testing device compared to diagnostic laboratory method 201
Pregnancy induction after bromocriptine-cyclofenil treatment in some normoprolactinemic anovulatory women. 195
Can Mediterranean Diet Counteract Metabolic Syndrome Diffusion? 193
Glycosylated LDL analyzed by electrophoretic mobility (E.M.). 192
Colorimetric versus radioimmunological measurement of glycated and non-glycated serum albumin after affinity chromatography. 190
Evidence indirectly confirming that plasma glucose decreases on storage at -20 degrees C. 188
Macro-creatine kinase isoenzyme (Macro-CK), a macromolecular form of a tumor-associated marker (CK-BB), in hypothyroidism. 188
Diagnosi precoce della nefropatia diabetica: risultati clinico-epidemiologici, aspetti fisiopatologici, ipotesi di lavoro. 187
MICROALBUMINURIA IN TYPE-I (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH AND WITHOUT RETINOPATHY 184
Microalbuminuria and endothelial dysfunction in essential hypertension. 184
Altered Proportions of Naïve, Central Memory and Terminally Differentiated Central Memory Subsets among CD4(+) and CD8 (+) T Cells Expressing CD26 in Patients with Type 1 Diabetes. 184
An optimized method to measure glycosylproteins: HPLC assay of 5-hydroxymethil-2-furfuraldehyde (5-HMF). 183
Enzimuria e tubulopatia diabetica: più di un semplice sospetto. 182
PREVALENCE AND TYPE OF SEXUAL DYSFUNCTIONS IN DIABETIC MALES - A STANDARDIZED CLINICAL APPROACH 182
Microalbuminuria and Erythrocyte Na+/H+ Exchange in Hypertension. Hemodynamic and Metabolic correlates. 182
Peripheral microvascular dysfunction as an independent predictor of atherosclerotic damage in type 1 diabetes patients: A preliminary study. 182
Basal insulin kinetics and glucose-stimulated secretion in untreated and treated diabetic patients and in normal subjects. 181
Valutazione del grado di conoscenza basale della malattia diabetica in pazienti ambulatoriali. 178
Circadian Rhythm of Blood Pressure in Diabetes Mellitus: Evidence, Mechanisms and Implications. 177
Circulating lipid levels and severity of diabetic retinopathy in type I diabetes mellitus. 177
FACTORS AFFECTING SERUM MYOGLOBIN LEVELS IN NORMAL POPULATION 176
Which method for 'microalbuminuria' in diabetes mellitus? 176
Terapia dell' infertilita' femminile normoprolattinemica: uso ed efficacia dell' associazione ciclofenile-bromocriptina (CB-154). 175
Dosaggio radioimmunologico della insulina plasmatica nella malattia diabetica. 174
Diabete ed educazione: ruolo ed utilità clinica dell'educazione formale 174
Circulating levels of myoglobin and muscle enzymes in uremics on regular dialytic treatment (RDT): effect of the single dialysis. 173
A protocol for the study of the effects of Glipizide on insulin metabolism in diabetic patients. 172
Dissociation between albuminuria and insulinaemia in hypertensive and atherosclerotic men 170
About CD26high CD8+ lymphocytes in type 1 diabetes mellitus. 170
Peripheral microvascular dysfunction as an independent predictor of atherosclerotic damage in type 1 diabetes patients: A preliminary study. 170
Metabolic control affects plasma lipid and apolipoprotein levels in women, but not in men, with IDDM 168
Statin intolerance: why and what to do - with a focus on diabetic people. 167
Preliminary results of pregnancy induction with drug combination cyclofenilbromocriptine. 166
Knowledge on diabetes and performance among health professionals in non-diabetological departments. 166
Aggregazione familiare di fattori di rischio cardiovascolare e di indicatori di disfunzione renale nel diabete mellito tipo 1. 165
Behavior of blood prolactin in secondary amenorrhea and in menstrual cycle disorders after gonadotropin releasing hormone and TRH administration. 164
Severe leukopenia and mild thrombocytopenia after chronic bromocriptine (CB-154) administration. 164
Exercise-induced proteinuria in well-trained athletes. 164
Terapia combinata bromocriptina-antiestrogeni (clomifene o ciclofenile) nella anovulatorieta' normoprolattinemica e nella oligospermia idiopatica. 163
Measurement of ATPases in red cells: setting up and validation of a highly reproducible method. 163
Effects of guar-pasta on serum lipid levels in obese diabetic and non-diabetic women with normal lipids. 163
Improving CardioChek PA analytical performance: three-year study. 163
Factitious hypoglycemia in an insulin-dependent woman in the eighth week of gestation 162
Four methods for glucose assay compared for various glucose concentrations and under different clinical conditions. 161
Comportamento della prolattina nelle amenorree secondarie e nei disordini del ciclo mestruale dopo GNRH e TRH. 160
Unusual prolactin response to luteinizing hormone-releasing hormone in some anovulatory women. 160
High rate of conception by cyclophenil-bromocryptine regimen in infertile women with normal prolactin levels. 160
Microalbuminuria in diabetes: which method to employ, which sample to collect. 159
Microalbuminuria in diabetes mellitus: more on urine storage and accuracy of colorimetric assays. 159
Guar-pasta: a new diet for obese subjects? 159
Prevalence of hypertension and microalbuminuria in adult type 1 (insulin-dependent) diabetic patients without renal failure in Italy. I. Validation of screening techniques to detect microalbuminuria. 158
Epidemiology of diabetic nephropathy in Europe 157
Antiproliferative properties of bromocryptine (CB-154) on human cells: a further rationale for medical management of pituitary macroadenomas. 156
'Microalbuminuria' in type I (insulin-dependent) diabetic patients with and without retinopathy. 156
Microalbuminuria and endothelial dysfunction in essential hypertension 156
Macro serum CK-BB in a woman with severe primary hypothyroidism. 155
Erithrocyte-antiport activity in hypertensive patients and cardiac hypertrophy. 28th Annual Meeting of the European Society for Clinical Investigation , Toledo, April 20-23, 1994 155
Iperprolattinemia "fasica" dopo LHRH nelle pazienti anovulatorie e sua terapia con bromocriptina (CB-154). 154
Terapia dell'infertilità normoprolattinemica nella donna e nell'uomo mediante l'associazione bromocriptina-antiestrogeni. 154
Orlistat a basse dosi (60 mg due volte/die) in obesi con sindrome metabolica: non solo perdita di peso. 154
Albuminuria estimated from proteinuria in diabetics. Is it a real alternative in clinical practice? 152
Effects of tiadenolo on hypercholesterolemic diabetic and non-diabetic patients. 152
Microalbuminuria is linked with abnormalities favoring atherosclerosis in type 2 diabetics. 152
ALBUMINURIA AND ENDOTHELIAL DYSFUNCTION IN HYPERTENSIVE SUBJECTS 151
Point-of-care testing for the sceening of dyslipidaemia: final results of a three-year independent evaluation protocol. 151
Abnormal circulating levels of muscle enzymes and myoglobin in hypothyroidism: their significance and usefulness in follow-up of replacement therapy of the metabolic disorder 150
Evidenza clinica e sperimentale dell'attivita' antimitotica della bromocriptina (CB-154). 150
Relation between microalbuminuria and diabetic retinopathy. 150
Risposta del GH al GHRH, alla clonidina ed al TRH nel diabete mellito tipo I. 150
Anthropometric indices of school children and familiar risk factors. 150
Ultrasonic myocardial texture and hyperinsulinemia in essential hypertension. 149
Il piede diabetico: diagnosi e terapia. 148
More on effects of storage time and temperature on measurement of small concentrations of albumin in urine. 147
Measurable deficit of autonomic and sensory nerve function in asymptomatic diabetic patients. 147
Amplitude loss of electrically and magnetically evoked sympathetic skin responses in early stages of type 1 (insulin-dependent) diabetes mellitus without signs of dysautonomia. 147
Ambulatory blood pressure monitoring and circadian rhythm of blood pressure in diabetes mellitus. 147
Validazione di due reflettometri di recente introduzione sul mercato per la determinazione della glicemia. 146
Female normoprolactinaemic infertility: a poorly defined clinical disturbance, a possible physiopathological mechanism, an effective regimen therapy. 145
Radioimmunological measurement of urinary albumin in diabetic patients and in normal subjects. 145
How and how long to store urine samples before albumin radioimmunoassay: a practical response. 145
Imipenem/cilastatin reduces cyclosporin-induced tubular damage in kidney transplant recipients 145
Bromocryptine-cyclofenil associated therapy: an effective and safe mode of treatment of female normoprolactinemic infertility. 144
Excretion of digoxin-like immunoreactivity in urine of normal subjects: correlations with excretion of creatinine and electrolytes. 144
A sensitive high performance liquid chromatographic method for determining small amounts of glycosylproteins. 144
More on effects of storage time and temperature on urinary enzymes: a 1-year study. 144
Erythrocyte Na+/H+ exchange and preclinical abnormalities of the left ventricular diastolic function in normotensive type 1 (insulin-dependent) diabetic patients. 143
Increased echodensity of myocardial wall in the diabetic heart: an ultrasound tissue characterization study. 143
Regulatory T cells with effector memory phenotype and glycaemic control in type 1 diabetes mellitus. 143
Circadian Blood pressure variability in type 1 diabetes subjects and their nondiabetic siblings – influence of erythrocyte electron transfer 143
Radioimmunological determination of the MB-isoenzyme of creatine-phosphokinase: comparison with immuno-enzymatic procedures. 142
Effetti di un nuovo contraccettivo trifasico contenente gestoden sul metabolismo glucidico e lipidico. 142
Totale 16.898
Categoria #
all - tutte 120.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021404 0 0 0 0 0 0 0 0 0 0 0 404
2021/20223.453 38 253 44 307 642 467 44 211 161 64 116 1.106
2022/20234.261 540 412 197 396 530 666 44 348 770 17 312 29
2023/20243.782 686 355 523 209 504 570 103 402 73 32 39 286
2024/20259.315 39 411 94 563 614 731 602 548 938 1.297 1.438 2.040
2025/20269.783 748 1.967 1.312 654 708 1.075 1.789 296 349 626 197 62
Totale 43.127